| | 33396-29-1 Basic information More.. |
| Product Name: | Erythromycin A Enol Ether | | Synonyms: | 11-(4-Dimethylamino-3-hydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-5-ethyl-3,4-dihydroxy-9-(5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydro-pyran-2-yloxy)-2,4,8,10,12,14-hexamethyl-6,15-dioxa-bicyclo[10.2.1]pentadec-1(14)-en-7-one;(6R)-6-Deoxy-9-deoxo-6,9-epoxy-8,9-didehydroerythromycin;6,9-Epoxy-8,9-didehydro-9-deoxo-6-deoxyerythromycin;6-Deoxy-9-deoxo-8,9-didehydro-6,9-epoxyerythromycin;6β,9-Epoxy-8,9-didehydro-9-deoxo-6-deoxyerythromycin;9-Deoxo-6-deoxy-6,9-epoxy-8,9-didehydroerythromycin;Erythromycin A Enol Ether;EM 523 | | CAS: | 33396-29-1 | | MF: | C37H65NO12 | | MW: | 715.91 | | EINECS: | | | Mol File: | 33396-29-1.mol |  |
Use
Erythromycin A enol ether is a degradation product of erythromycin formed under acidic conditions by C6–OH internal attack on the C9 ketone to produce a cyclic enol ether. The rearrangement results in a loss of antibiotic activity. This single reaction was the prime driver for the development of second and third generation erythromycins. Erythromycin A enol ether is an important standard for stability studies.
|
|
33396-29-1
Recommend Suppliers |
|